ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Safety Pharmacology Profiling Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-19I12041
Home | Market Reports | Health| Pharmacy
Global In Vitro Safety Pharmacology Profiling Market Research Report 2022
BUY CHAPTERS

Global In Vitro Safety Pharmacology Profiling Market Research Report 2025

Code: QYRE-Auto-19I12041
Report
January 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Tergus Pharma
QIMA Life Sciences
PerkinElmer Inc
Thermo Fisher Scientific

In Vitro Safety Pharmacology Profiling Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

In Vitro Safety Pharmacology Profiling Market

In Vitro Safety Pharmacology Profiling Market

The global market for In Vitro Safety Pharmacology Profiling was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro Safety Pharmacology Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Safety Pharmacology Profiling.
The In Vitro Safety Pharmacology Profiling market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Safety Pharmacology Profiling market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Safety Pharmacology Profiling companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vitro Safety Pharmacology Profiling Market Report

Report Metric Details
Report Name In Vitro Safety Pharmacology Profiling Market
CAGR 5%
Segment by Type
  • GPCRs
  • Nuclear Receptors
  • Cytochrome P450s
  • Ion Channels
  • Other
Segment by Application
  • Oncology
  • Cardiovascular System
  • Central Nervous System
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In Vitro Safety Pharmacology Profiling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the In Vitro Safety Pharmacology Profiling Market report?

Ans: The main players in the In Vitro Safety Pharmacology Profiling Market are Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences

What are the Application segmentation covered in the In Vitro Safety Pharmacology Profiling Market report?

Ans: The Applications covered in the In Vitro Safety Pharmacology Profiling Market report are Oncology, Cardiovascular System, Central Nervous System, Others

What are the Type segmentation covered in the In Vitro Safety Pharmacology Profiling Market report?

Ans: The Types covered in the In Vitro Safety Pharmacology Profiling Market report are GPCRs, Nuclear Receptors, Cytochrome P450s, Ion Channels, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GPCRs
1.2.3 Nuclear Receptors
1.2.4 Cytochrome P450s
1.2.5 Ion Channels
1.2.6 Other
1.3 Market by Application
1.3.1 Global In Vitro Safety Pharmacology Profiling Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular System
1.3.4 Central Nervous System
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Safety Pharmacology Profiling Market Perspective (2020-2031)
2.2 Global In Vitro Safety Pharmacology Profiling Growth Trends by Region
2.2.1 Global In Vitro Safety Pharmacology Profiling Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Safety Pharmacology Profiling Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Safety Pharmacology Profiling Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Safety Pharmacology Profiling Market Dynamics
2.3.1 In Vitro Safety Pharmacology Profiling Industry Trends
2.3.2 In Vitro Safety Pharmacology Profiling Market Drivers
2.3.3 In Vitro Safety Pharmacology Profiling Market Challenges
2.3.4 In Vitro Safety Pharmacology Profiling Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Safety Pharmacology Profiling Players by Revenue
3.1.1 Global Top In Vitro Safety Pharmacology Profiling Players by Revenue (2020-2025)
3.1.2 Global In Vitro Safety Pharmacology Profiling Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Safety Pharmacology Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Safety Pharmacology Profiling Revenue
3.4 Global In Vitro Safety Pharmacology Profiling Market Concentration Ratio
3.4.1 Global In Vitro Safety Pharmacology Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Safety Pharmacology Profiling Revenue in 2024
3.5 Global Key Players of In Vitro Safety Pharmacology Profiling Head office and Area Served
3.6 Global Key Players of In Vitro Safety Pharmacology Profiling, Product and Application
3.7 Global Key Players of In Vitro Safety Pharmacology Profiling, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Safety Pharmacology Profiling Breakdown Data by Type
4.1 Global In Vitro Safety Pharmacology Profiling Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Safety Pharmacology Profiling Forecasted Market Size by Type (2026-2031)
5 In Vitro Safety Pharmacology Profiling Breakdown Data by Application
5.1 Global In Vitro Safety Pharmacology Profiling Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Safety Pharmacology Profiling Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Safety Pharmacology Profiling Market Size (2020-2031)
6.2 North America In Vitro Safety Pharmacology Profiling Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025)
6.4 North America In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Safety Pharmacology Profiling Market Size (2020-2031)
7.2 Europe In Vitro Safety Pharmacology Profiling Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025)
7.4 Europe In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Safety Pharmacology Profiling Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Safety Pharmacology Profiling Market Size (2020-2031)
9.2 Latin America In Vitro Safety Pharmacology Profiling Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025)
9.4 Latin America In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Safety Pharmacology Profiling Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vitro Safety Pharmacology Profiling Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer In Vitro Safety Pharmacology Profiling Introduction
11.2.4 PerkinElmer Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck In Vitro Safety Pharmacology Profiling Introduction
11.3.4 Merck Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River In Vitro Safety Pharmacology Profiling Introduction
11.4.4 Charles River Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.4.5 Charles River Recent Development
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vitro Safety Pharmacology Profiling Introduction
11.5.4 Pharmaron Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.5.5 Pharmaron Recent Development
11.6 Reaction Biology
11.6.1 Reaction Biology Company Details
11.6.2 Reaction Biology Business Overview
11.6.3 Reaction Biology In Vitro Safety Pharmacology Profiling Introduction
11.6.4 Reaction Biology Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.6.5 Reaction Biology Recent Development
11.7 Eurofins Discovery
11.7.1 Eurofins Discovery Company Details
11.7.2 Eurofins Discovery Business Overview
11.7.3 Eurofins Discovery In Vitro Safety Pharmacology Profiling Introduction
11.7.4 Eurofins Discovery Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.7.5 Eurofins Discovery Recent Development
11.8 Frontage Laboratories
11.8.1 Frontage Laboratories Company Details
11.8.2 Frontage Laboratories Business Overview
11.8.3 Frontage Laboratories In Vitro Safety Pharmacology Profiling Introduction
11.8.4 Frontage Laboratories Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.8.5 Frontage Laboratories Recent Development
11.9 Tergus Pharma
11.9.1 Tergus Pharma Company Details
11.9.2 Tergus Pharma Business Overview
11.9.3 Tergus Pharma In Vitro Safety Pharmacology Profiling Introduction
11.9.4 Tergus Pharma Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.9.5 Tergus Pharma Recent Development
11.10 QIMA Life Sciences
11.10.1 QIMA Life Sciences Company Details
11.10.2 QIMA Life Sciences Business Overview
11.10.3 QIMA Life Sciences In Vitro Safety Pharmacology Profiling Introduction
11.10.4 QIMA Life Sciences Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025)
11.10.5 QIMA Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Tergus Pharma
QIMA Life Sciences
PerkinElmer Inc
Thermo Fisher Scientific
List of Tables
 Table 1. Global In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of GPCRs
 Table 3. Key Players of Nuclear Receptors
 Table 4. Key Players of Cytochrome P450s
 Table 5. Key Players of Ion Channels
 Table 6. Key Players of Other
 Table 7. Global In Vitro Safety Pharmacology Profiling Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global In Vitro Safety Pharmacology Profiling Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global In Vitro Safety Pharmacology Profiling Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global In Vitro Safety Pharmacology Profiling Market Share by Region (2020-2025)
 Table 11. Global In Vitro Safety Pharmacology Profiling Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global In Vitro Safety Pharmacology Profiling Market Share by Region (2026-2031)
 Table 13. In Vitro Safety Pharmacology Profiling Market Trends
 Table 14. In Vitro Safety Pharmacology Profiling Market Drivers
 Table 15. In Vitro Safety Pharmacology Profiling Market Challenges
 Table 16. In Vitro Safety Pharmacology Profiling Market Restraints
 Table 17. Global In Vitro Safety Pharmacology Profiling Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global In Vitro Safety Pharmacology Profiling Market Share by Players (2020-2025)
 Table 19. Global Top In Vitro Safety Pharmacology Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Safety Pharmacology Profiling as of 2024)
 Table 20. Ranking of Global Top In Vitro Safety Pharmacology Profiling Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by In Vitro Safety Pharmacology Profiling Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of In Vitro Safety Pharmacology Profiling, Headquarters and Area Served
 Table 23. Global Key Players of In Vitro Safety Pharmacology Profiling, Product and Application
 Table 24. Global Key Players of In Vitro Safety Pharmacology Profiling, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global In Vitro Safety Pharmacology Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global In Vitro Safety Pharmacology Profiling Revenue Market Share by Type (2020-2025)
 Table 28. Global In Vitro Safety Pharmacology Profiling Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global In Vitro Safety Pharmacology Profiling Revenue Market Share by Type (2026-2031)
 Table 30. Global In Vitro Safety Pharmacology Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global In Vitro Safety Pharmacology Profiling Revenue Market Share by Application (2020-2025)
 Table 32. Global In Vitro Safety Pharmacology Profiling Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global In Vitro Safety Pharmacology Profiling Revenue Market Share by Application (2026-2031)
 Table 34. North America In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Thermo Fisher Scientific Company Details
 Table 50. Thermo Fisher Scientific Business Overview
 Table 51. Thermo Fisher Scientific In Vitro Safety Pharmacology Profiling Product
 Table 52. Thermo Fisher Scientific Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 53. Thermo Fisher Scientific Recent Development
 Table 54. PerkinElmer Company Details
 Table 55. PerkinElmer Business Overview
 Table 56. PerkinElmer In Vitro Safety Pharmacology Profiling Product
 Table 57. PerkinElmer Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 58. PerkinElmer Recent Development
 Table 59. Merck Company Details
 Table 60. Merck Business Overview
 Table 61. Merck In Vitro Safety Pharmacology Profiling Product
 Table 62. Merck Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 63. Merck Recent Development
 Table 64. Charles River Company Details
 Table 65. Charles River Business Overview
 Table 66. Charles River In Vitro Safety Pharmacology Profiling Product
 Table 67. Charles River Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 68. Charles River Recent Development
 Table 69. Pharmaron Company Details
 Table 70. Pharmaron Business Overview
 Table 71. Pharmaron In Vitro Safety Pharmacology Profiling Product
 Table 72. Pharmaron Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 73. Pharmaron Recent Development
 Table 74. Reaction Biology Company Details
 Table 75. Reaction Biology Business Overview
 Table 76. Reaction Biology In Vitro Safety Pharmacology Profiling Product
 Table 77. Reaction Biology Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 78. Reaction Biology Recent Development
 Table 79. Eurofins Discovery Company Details
 Table 80. Eurofins Discovery Business Overview
 Table 81. Eurofins Discovery In Vitro Safety Pharmacology Profiling Product
 Table 82. Eurofins Discovery Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 83. Eurofins Discovery Recent Development
 Table 84. Frontage Laboratories Company Details
 Table 85. Frontage Laboratories Business Overview
 Table 86. Frontage Laboratories In Vitro Safety Pharmacology Profiling Product
 Table 87. Frontage Laboratories Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 88. Frontage Laboratories Recent Development
 Table 89. Tergus Pharma Company Details
 Table 90. Tergus Pharma Business Overview
 Table 91. Tergus Pharma In Vitro Safety Pharmacology Profiling Product
 Table 92. Tergus Pharma Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 93. Tergus Pharma Recent Development
 Table 94. QIMA Life Sciences Company Details
 Table 95. QIMA Life Sciences Business Overview
 Table 96. QIMA Life Sciences In Vitro Safety Pharmacology Profiling Product
 Table 97. QIMA Life Sciences Revenue in In Vitro Safety Pharmacology Profiling Business (2020-2025) & (US$ Million)
 Table 98. QIMA Life Sciences Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. In Vitro Safety Pharmacology Profiling Picture
 Figure 2. Global In Vitro Safety Pharmacology Profiling Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vitro Safety Pharmacology Profiling Market Share by Type: 2024 VS 2031
 Figure 4. GPCRs Features
 Figure 5. Nuclear Receptors Features
 Figure 6. Cytochrome P450s Features
 Figure 7. Ion Channels Features
 Figure 8. Other Features
 Figure 9. Global In Vitro Safety Pharmacology Profiling Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global In Vitro Safety Pharmacology Profiling Market Share by Application: 2024 VS 2031
 Figure 11. Oncology Case Studies
 Figure 12. Cardiovascular System Case Studies
 Figure 13. Central Nervous System Case Studies
 Figure 14. Others Case Studies
 Figure 15. In Vitro Safety Pharmacology Profiling Report Years Considered
 Figure 16. Global In Vitro Safety Pharmacology Profiling Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global In Vitro Safety Pharmacology Profiling Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global In Vitro Safety Pharmacology Profiling Market Share by Region: 2024 VS 2031
 Figure 19. Global In Vitro Safety Pharmacology Profiling Market Share by Players in 2024
 Figure 20. Global Top In Vitro Safety Pharmacology Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Safety Pharmacology Profiling as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by In Vitro Safety Pharmacology Profiling Revenue in 2024
 Figure 22. North America In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America In Vitro Safety Pharmacology Profiling Market Share by Country (2020-2031)
 Figure 24. United States In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe In Vitro Safety Pharmacology Profiling Market Share by Country (2020-2031)
 Figure 28. Germany In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific In Vitro Safety Pharmacology Profiling Market Share by Region (2020-2031)
 Figure 36. China In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America In Vitro Safety Pharmacology Profiling Market Share by Country (2020-2031)
 Figure 44. Mexico In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa In Vitro Safety Pharmacology Profiling Market Share by Country (2020-2031)
 Figure 48. Turkey In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE In Vitro Safety Pharmacology Profiling Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 52. PerkinElmer Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 54. Charles River Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 55. Pharmaron Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 56. Reaction Biology Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 57. Eurofins Discovery Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 58. Frontage Laboratories Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 59. Tergus Pharma Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 60. QIMA Life Sciences Revenue Growth Rate in In Vitro Safety Pharmacology Profiling Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ibuprofen Sodium​ API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30X13296
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11U13426
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-16160
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-10G2665
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions